Received May 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 59MC4 | — |
patient was only given the liquid; patient was only given the liquid; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a male patient who received Herpes zoster (Shingrix) (batch number 59MC4, expiry date 10-MAR-2027) for prophylaxis. On 13-MAY-2025, the patient received the 1st dose of Shingrix. On 13-MAY-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: patient was only given the liquid) and inappropriate dose of vaccine administered (Verbatim: patient was only given the liquid). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 13-MAY-2025 The healthcare professional stated that on the day of reporting another staff member prepared the dose to be administered to a male patient, and the staff member did not know it was two vials, so the patient was only given the liquid. She confirms this was intended to be the first dose of the series, and this occurred this morning, 13 May 2025. The patient received only adjuvant of Shingrix, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.